20 Confirmed Participants in 2019
Aesica, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Guerbet, Janssen, Merck Serono, Novartis, NovoNordisk, Orion, Pfizer, Roche, Sanofi, SGS, Vetter, Vifor Pharma, Elanco, Synthon, Takeda and AstraZeneca.

 

Mode of Interaction
In 2018, we launched an exchange platform specifically focused on QC lab excellence. The platform allows the participants to share and learn from successful practices of pharmaceutical companies. It combines presentations, workshops and in-depth discussions between global QC lab specialist and network excellence leaders with other specialists from pharmaceutical companies. In total, three 2-days meetings per year are planned.

 

Objective
We want to enable the industry to discuss the exchange topics that are most relevant for the participants. The participants are able to define the topics themselves. Our goal is to allow better problem solving in each of the participants' organizations. The focus topics in year one included performance management, work & schedule planning, and digitalization. The key topics of the second year meetings will be announced shortly.

 

Timeline
The kick-off meeting will take place on 20 and 21 May 2019. Further meetings will take place on 2 and 3 September and on 19 and 20 November.

If you are interested to learn more about the exchange platform please contact Stephan Köhler.

 

 

 

 

16 Participants in 2018
Aesica, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Guerbet, Janssen, Merck Serono, Novartis, NovoNordisk, Orion, Pfizer, Roche, Sanofi, SGS, Vetter, and SGS..